These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11499461)

  • 1. Effectiveness of NEO-PI-R research validity scales for discriminating analog malingering and genuine psychopathology.
    Berry DT; Bagby RM; Smerz J; Rinaldo JC; Caldwell-Andrews A; Baer RA
    J Pers Assess; 2001 Jun; 76(3):496-516. PubMed ID: 11499461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and utility of the positive presentation management and negative presentation management scales for the Revised NEO Personality Inventory.
    Sellbom M; Bagby RM
    Assessment; 2008 Jun; 15(2):165-76. PubMed ID: 18463407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Validity Scales for the NEO-PI-R: additional evidence for reliability and validity.
    Young MS; Schinka JA
    J Pers Assess; 2001 Jun; 76(3):412-20. PubMed ID: 11499455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of response sets on NEO-PI-R scores and their relations to external criteria.
    Caldwell-Andrews A; Baer RA; Berry DT
    J Pers Assess; 2000 Jun; 74(3):472-88. PubMed ID: 10900573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Infrequency-Psychopathology scale for the MMPI-A: the Fp-A Scale.
    McGrath RE; Pogge DL; Stein LA; Graham JR; Zaccario M; Piacentini T
    J Pers Assess; 2000 Apr; 74(2):282-95. PubMed ID: 10879356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of positive impression management on the NEO Personality Inventory--Revised in a clinical population.
    Ballenger JF; Caldwell-Andrews A; Baer RA
    Psychol Assess; 2001 Jun; 13(2):254-60. PubMed ID: 11433800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of the NEO-PI-R validity scales to detect response distortion: a comparison with the MMPI-2.
    Morasco BJ; Gfeller JD; Elder KA
    J Pers Assess; 2007 Jun; 88(3):276-83. PubMed ID: 17518549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the Deceptive-Subtle items in the detection of malingering.
    Bagby RM; Nicholson R; Buis T
    J Pers Assess; 1998 Jun; 70(3):405-15. PubMed ID: 9841263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for malingering in a criminal-forensic sample with the personality assessment inventory.
    Boccaccini MT; Murrie DC; Duncan SA
    Psychol Assess; 2006 Dec; 18(4):415-23. PubMed ID: 17154762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental manipulation of NEO-PI-R items.
    Haigler ED; Widiger TA
    J Pers Assess; 2001 Oct; 77(2):339-58. PubMed ID: 11693863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of the Malingering Discriminant Function Index for the MMPI-2.
    Bacchiochi JR; Bagby RM
    J Pers Assess; 2006 Aug; 87(1):51-61. PubMed ID: 16856786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance or style? An investigation of the NEO-PI-R validity scales.
    Morey LC; Quigley BD; Sanislow CA; Skodol AE; McGlashan TH; Shea MT; Stout RL; Zanarini MC; Gunderson JG
    J Pers Assess; 2002 Dec; 79(3):583-99. PubMed ID: 12511022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of malingering: validation of the Structured Inventory of Malingered Symptomatology (SIMS).
    Smith GP; Burger GK
    J Am Acad Psychiatry Law; 1997; 25(2):183-9. PubMed ID: 9213290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative capacity of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and MMPI-2 Restructured Form (MMPI-2-RF) validity scales to detect suspected malingering in a disability claimant sample.
    Chmielewski M; Zhu J; Burchett D; Bury AS; Bagby RM
    Psychol Assess; 2017 Feb; 29(2):199-208. PubMed ID: 27183046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of MMPI-A items in discriminating between normative and clinical samples.
    Archer RP; Handel RW; Lynch KD
    J Pers Assess; 2001 Dec; 77(3):420-35. PubMed ID: 11781030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.